In this study we have examined the relationship of benzo[a]pyrene (B[a]P) exposure with B[a]P-7,8-diol-9,10-epoxide (BPDE) adduct formation in globin and serum albumin (SA). We also have evaluated the relationship of BPDE-globin and -SA adduct formation with urinary 1 -hydroxypyrene ( 1 -OH-pyrene), and bulky DNA adducts in peripheral blood lymphocytes. The study groups consist of male Hungarian garage mechanics (smokers and nonsmokers) exposed to diesel engine exhaust and matched control samples from a blood bank in Budapest. The mean level of BPDEglobin adducts in the garage mechanics (n=15) is 5.914.8 fmoVmg globin (ranging from 0.5 to 19.9 fmol/mg globin) and that in controls (n=15), is 2.4*2.5 fmol/mg globin (ranging from ND to 8.5 fmol BPDE/mg globin). The mean of BPDE-SA in garage mechanics is 0.3650.6 fmol/mg SA (ranging from ND to 2.6 fmol/mg SA) and, in controls it is 0.29i0.3 fmol/mg SA (ranging from ND to 1.3 fmol/mg SA). The results of this study indicate that levels of BPDE-SA adducts are about one order of magnitude lower than levels of globin adducts. The mean of BPDE-globin and -SA adducts in garage mechanics are 2.4-fold (p=0.02) and 1.2-fold @=0.7) higher than I15 I26
A. A. MELIKIAN e t a /those in controls, respectively. Similarly, levels of urinary 1 -0H-pyrene in the exposed group are 2.1 -fold higher than those in controls @=0.03). The correlation coefficients between estimated B[n]P exposure (both ingested and inhaled) and formation of globin adducts and urinary 1-OH-pyrene are ~0 . 4 9 (p=0.06), and r=0.3 1 (p=0.26), respectively. This study suggests that BPDE-globin adducts and urinary 1-OH-pyrene may be better biomarkers of exposure than BPDE-SA adducts.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.